Journal
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 19, Issue 3, Pages 309-322Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14787210.2020.1816824
Keywords
Antimicrobials; bacteriocin; colicin; microcin; Escherichia; E; coli; probiotic; Shigella; virulence; diarrhea
Funding
- Faculty of Medicine MU [ROZV/23/LF13/2019, ROZV/28/LF/2020]
Ask authors/readers for more resources
Bacteriocins, peptides or proteins with relatively narrow spectra of antibacterial activities produced by various bacterial species, represent a potential alternative to antibiotic treatment. They have potential applications in human and animal medicine, as well as in the food industry.
Introduction The emergence and spread of antibiotic resistance among pathogenic bacteria drives the search for alternative antimicrobial therapies. Bacteriocins represent a potential alternative to antibiotic treatment. In contrast to antibiotics, bacteriocins are peptides or proteins that have relatively narrow spectra of antibacterial activities and are produced by a wide range of bacterial species. Bacteriocins ofEscherichia coliare historically classified as microcins and colicins, and, until now, more than 30 different bacteriocin types have been identified and characterized. Areas covered We performed bibliographical searches of online databases to review the literature regarding bacteriocins produced byE. coliwith respect to their occurrence, bacteriocin role in bacterial colonization and pathogenicity, and application of their antimicrobial effect. Expert opinion The potential use of bacteriocins for applications in human and animal medicine and the food industry includes (i) the use of bacteriocin-producing probiotic strains, (ii) recombinant production in plants and application in food, and (iii) application of purified bacteriocins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available